Skip to search formSkip to main contentSkip to account menu

Acyclovir 800 MG Oral Tablet

Known as: ACYCLOVIR 800MG TAB,UD [VA Product], ACYCLOVIR 800MG TAB,UD, ACYCLOVIR 800MG TAB [VA Product] 
National Institutes of Health

Related topics

Related topics

30 relations
AIDS-Related Opportunistic InfectionsAcyclovirChickenpoxCroscarmellose Sodium

Broader (1)

Antiviral Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Synthesis and in vitro evaluation of antiviral and cytostatic properties of novel 8-triazolyl acyclovir derivatives
Abstract As a part of the research aimed on identification of new nucleobase derivatives with improved biological properties, a… 
2017
2017
Structure-Activity Relationships of Acyclic Selenopurine Nucleosides as Antiviral Agents
A series of acyclic selenopurine nucleosides 3a–f and 4a–g were synthesized based on the bioisosteric rationale between oxygen… 
2015
2015
Long-term stability of acyclovir in 0.9% NaCl infusion polyolefin bags at 5±3°C after freeze-thaw treatment: a generic product versus the brand name.
Review
2014
Review
2014
Acyclovir Lauriad®: a muco-adhesive buccal tablet for the treatment of recurrent herpes labialis
The treatment of recurrent herpes labialis remains a challenge in the 21st century. The virus is ubiquitous and there is no… 
Highly Cited
2014
Highly Cited
2014
Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin
Abstract The therapeutic potential of acyclovir is limited by the low oral bioavailability owing to its limited aqueous… 
2010
2010
A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
BACKGROUND Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) are responsible for 2 intersecting… 
2008
2008
Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
Highly Cited
2004
Highly Cited
2004
Increased acyclovir oral bioavailability via a bile acid conjugate.
The objective of this work was to design an acyclovir prodrug that would utilize the human apical sodium-dependent bile acid… 
Highly Cited
2003
Highly Cited
2003
In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
PURPOSE A dipeptide prodrug of the antiviral nucleoside acyclovir (ACV), val-val-ACV (VVACV), was evaluated in vivo as a… 
2000
2000
Synthesis and Antiviral Evaluation of 1-O-Hexadecylpropanediol-3-P-acyclovir: Efficacy Against HSV-1 Infection in Mice
Abstract We synthesized, 1-O-hexadecylpropanediol-3–P-acyclovir, an orally bioavailable lipid prodrug of acyclovir and evaluated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)